Challenges in classification of asthma severity from prescription data: a pilot study Source: Annual Congress 2009 - Towards improving asthma control Year: 2009
Dispensed asthma therapy and medical resource utilisation in asthma patients: results from the L777 observational study Source: Annual Congress 2009 - Epidemiology of asthma Year: 2009
Cost-effectiveness of antibiotics for COPD management: observational analysis using CPRD data Source: ERJ Open Res, 3 (2) 00085-2016; 10.1183/23120541.00085-2016 Year: 2017
An electronic alert to reduce excessive prescribing of short-acting beta2-agonists for people with asthma in East London: a retrospective case-control study using routine primary care data Source: Virtual Congress 2020 – Digital health interventions in respiratory medicine Year: 2020
SABINA: global programme to evaluate prescriptions and clinical outcomes related to short-acting ß2 -agonist use in asthma Source: Eur Respir J, 55 (2) 1901858; 10.1183/13993003.01858-2019 Year: 2020
Inadequate assessment of adherence to maintenance medication leads to loss of power and increased costs in trials of severe asthma therapy: results from a systematic literature review and modelling study Source: Eur Respir J, 53 (5) 1802161; 10.1183/13993003.02161-2018 Year: 2019
Asthma severity, poor control, co-morbidities and prior resource use determined omalizumab prescriptions in a nested case-control study with US claims data Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015
DuoResp Spiromax adherence, satisfaction and ease of use: findings from a multi-country observational study in patients with asthma and COPD (SPRINT) Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies Year: 2018
Utility of adherence checks in patients with severe asthma eligible for biologics: a single centre retrospective analysis Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021
Cost impact of time to initiation of triple therapy in COPD patients in Japan: A retrospective analysis of healthcare claims data Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients? Year: 2017
General practice and office spirometry in asthma and COPD: preliminary data from the prospective, randomised, comparative ²SPACE² Italian study Source: Eur Respir J 2004; 24: Suppl. 48, 87s Year: 2004
Costs and effects of structured COPD care – An observational, matched-cohort study Source: Annual Congress 2013 –Early diagnosis and effectiveness of disease management in primary care Year: 2013
Persistence to COPD therapies and impact on exacerbations: a French claims data study Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections Year: 2018
Demographic, clinical and health care resource utilisation characterisation of patients prescribed omalizumab: A retrospective, real world data study Source: International Congress 2014 – Intervening in allergic asthma Year: 2014
The Spanish national clinical audit on COPD exacerbations. Results of a pilot study: main outcomes Source: Annual Congress 2008 - Prognosis in COPD Year: 2008
The Spanish national clinical audit on COPD exacerbations. results of a pilot study: spirometry outcomes Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008
What predicts poor collection of medication among children with asthma? A case-control study Source: Eur Respir J 2002; 20: 1464-1469 Year: 2002
A national database study of the effectiveness of switching real-life asthma patients to fostair Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015
Are COPD prescription patterns aligned with guidelines? a population-based study Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies Year: 2021
Healthcare costs associated with short-acting ß2-agonist use in asthma: an observational UK study from the SABINA global programme Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021